In Brief: Varian
This article was originally published in The Gray Sheet
Executive Summary
Varian: Receives FDA 510(k) clearance for its VariSource high dose rate remote afterloader, a computer-controlled brachytherapy cancer treatment system, the Palo Alto, California firm announces. The device, which utilizes a catheter and applicators to position a radioactive isotope "directly in or next to tumor sites," is often used to treat gynecological and lung cancers and can also supplement conventional external beam radiotherapy and types of surgery, the firm states...